Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
PA-23-189 |
2026-05-08 |
|
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) |
PAR-23-139 |
2025-05-30 |
|
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) |
PAS-23-086 |
2026-05-07 |
|
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) |
PA-25-304 |
2028-01-08 |
|
NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigatorsto Promote Workforce Diversity (R01 Clinical Trial Optional) |
PAR-22-181 |
2025-06-07 |
|
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
PAR-24-280 |
2026-11-03 |
|
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions(R15 Clinical Trial Not Allowed) |
PAR-24-152 |
2027-05-08 |
|
Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) |
RFA-MH-26-110 |
2025-03-18 |
|
Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed) |
RFA-AI-24-080 |
2025-03-03 |
|
NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed) |
PAR-24-126 |
2026-05-26 |
|
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
PAR-23-029 |
2025-03-29 |
|
UNITED STATES MILITARY ACADEMY Broad Agency Announcement |
W911NF-20-S-0008 |
2025-03-31 |
Areomedical Evacuation, Artificial Intelligence, Combat Casualty Care , Environmental health & protection, Force Health Protection, Human Performance , Medical Countermeasures, Other, Performance optimization, Physiological health, Prolonged Field Care, Robotics |
World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) |
RFA-OH-24-004 |
2025-10-29 |
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) |
PAR-23-194 |
2025-06-16 |
|
NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required) |
PAR-22-149 |
2025-05-07 |
vision, Clinical Trial |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
PAR-22-216 |
2025-07-01 |
Cancer |
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) |
PAR-22-142 |
2025-03-10 |
Neuroscience, Clinical Trial |
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
PA-25-303 |
2028-01-08 |
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) |
PAR-25-347 |
2026-09-08 |
|
2025 Brain & Behavior Research Foundation Young Investigator (YI) Grant |
2025 BBRF YI GRANT |
2025-03-12 |
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
PAR-23-313 |
2026-10-15 |
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) |
PA-21-265 |
2025-05-27 |
|
PAR-24-035: Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) |
PAR-24-035 |
2026-11-02 |
|
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) |
RFA-DA-26-003 |
2025-03-13 |
|
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
PAR-24-091 |
2027-01-08 |
|
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
RFA-EB-22-002 |
2025-06-18 |
|
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) |
PAR-25-054 |
2025-03-11 |
|
NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional) |
PAR-25-249 |
2025-09-08 |
|
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) |
RFA-HL-26-018 |
2027-12-24 |
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
PAR-25-273 |
2028-01-08 |
|
Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) |
PAR-22-200 |
2025-09-02 |
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
PAR-22-225 |
2025-09-08 |
|
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) |
PAR-22-076 |
2025-05-07 |
Neuroscience |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) |
PAR-22-242 |
2025-09-08 |
|
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) |
PAR-24-111 |
2027-01-07 |
|
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) |
PAR-22-135 |
2025-05-07 |
vision |
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) |
PA-22-047 |
2026-10-30 |
Antibiotic Resistance, Wound Healing and Infections |
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
PAR-24-100 |
2027-01-14 |
|
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) |
PAR-23-058 |
2026-01-08 |
|
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) |
PAR-25-275 |
2025-03-01 |
|
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed) |
PAR-23-297 |
2026-09-08 |
|
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
PAR-24-075 |
2026-12-29 |
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
PA-25-301 |
2028-01-08 |
Antibiotic Resistance, Biomarkers, Blood and Blood products, Cancer, Cardiology/Cardiovascular, Clinical/Rehabilitative Research , Dentistry, Diagnostics, Emerging Infectious Diseases, Expeditionary Nursing, Immune Function, Infectious Disease , Mental Health, NeuroMusculoskeletal injury, Neuroscience, Nursing, Nutrition, Orthopedics, Other, Pain Management, Pediatrics, Physiological health, Precision Medicine , Sleep, Substance Abuse, Women's Health, Wound Healing and Infections |
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) |
PAR-23-239 |
2026-09-08 |
|
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) |
PA-20-190 |
2026-09-08 |
|
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) |
RFA-EB-21-001 |
2025-05-02 |
|
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research GrantApplications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (FY24) |
PA-24-245 |
2025-04-06 |
|
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) |
PAR-23-062 |
2026-01-10 |
|
NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) |
PAR-23-265 |
2025-05-26 |
|
Catalyze Product Definition – Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) |
RFA-HL-26-019 |
2027-12-24 |
|
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01 |
PA-23-291 |
2028-07-06 |
|
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) |
PA-25-150 |
2028-01-08 |
|
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) |
PAR-22-180 |
2025-05-17 |
|
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) |
PAR-25-238 |
2026-01-08 |
|
NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) |
PA-24-194 |
2027-05-07 |
|
Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
|
BAA-23-100-SOL-00004 |
2028-09-25 |
|
CMTRF Young Researcher Innovation Grants (YRIG) |
CMTRF YRIG Pilot Grants |
2025-02-28 |
|
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
PAR-25-134 |
2028-01-08 |
|
USSOCOM BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development (FY24) |
HT9425-23-S-SOC1 |
2028-07-31 |
|
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) |
PA-25-280 |
2028-05-08 |
|
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
PAR-22-189 |
2025-09-11 |
Clinical Trial, Blood and Blood products, Cardiology/Cardiovascular, pulmonary disease |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
PA-25-302 |
2028-01-08 |
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) |
PAR-25-347 |
2026-09-08 |
|
Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) |
PAR-23-145 |
2026-02-04 |
|
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) |
PAR-22-162 |
2025-02-28 |
Cancer |
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) |
PAR-22-141 |
2025-05-07 |
vision |
Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed) |
PAR-23-236 |
2026-01-26 |
|
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) |
PAR-23-034 |
2026-01-08 |
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
PA-23-189 |
2026-05-08 |
|